Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Green

Showing results (1141-1150 of 1,341) with videos related to

Pageof 135
Sort By:
Biochemistry|September 26, 2001
Binding of correolide to the K(v)1.3 potassium channel: characterization of the binding domain by site-directed mutagenesisM Hanner, B Green, Y D Gao, et al.
Contemporary Clinical Trials|August 27, 2022
Reach in a pragmatic hypertension trial: A critical RE-AIM componentMeghan JaKa, Anna Bergdall, Mary Sue Beran, et al.
Women'S Health Reports (New Rochelle, N.Y.)|September 10, 2025
Improving Communication and Management Following a Positive Home HPV Self-Sampling Result: Comparing Intervention Strategies Between the HOME and STEP TrialsJasmin A Tiro, Meera Muthukrishnan, Sadie Metcalfe, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2010
A circadian-regulated gene, Nocturnin, promotes adipogenesis by stimulating PPAR-gamma nuclear translocationMasanobu Kawai, Carla B Green, Beata Lecka-Czernik, et al.
European Journal of Preventive Cardiology|November 27, 2024
Albiglutide and atrial fibrillation in patients with type 2 diabetes and established cardiovascular disease - insights from the Harmony Outcomes trialKonstantin A Krychtiuk, Guillaume Marquis-Gravel, Shannon Murphy, et al.
Neurosurgery|April 1, 2006
GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysisArash J Gabayan, Sylvan B Green, Abhay Sanan, et al.
American Heart Journal|November 11, 2019
Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOSNeha J Pagidipati, Yinggan Zheng, Jennifer B Green, et al.
Journal of the American Heart Association|January 12, 2021
Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular DiseaseAdam J Nelson, Maddalena Ardissino, Kevin Haynes, et al.
Hypertension (Dallas, Tex. : 1979)|September 14, 2020
Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension: An International Expert Position PaperStefano Omboni, Richard J McManus, Hayden B Bosworth, et al.
Journal of Dairy Science|September 18, 2017
Characterizing effects of feed restriction and glucagon-like peptide 2 administration on biomarkers of inflammation and intestinal morphologyS K Kvidera, E A Horst, M V Sanz Fernandez, et al.
Pageof 135

Showing results (1141-1150 of 1,341) with videos related to

Sort By:
Pageof 135
Biochemistry|September 26, 2001
Binding of correolide to the K(v)1.3 potassium channel: characterization of the binding domain by site-directed mutagenesisM Hanner, B Green, Y D Gao, et al.
Contemporary Clinical Trials|August 27, 2022
Reach in a pragmatic hypertension trial: A critical RE-AIM componentMeghan JaKa, Anna Bergdall, Mary Sue Beran, et al.
Women'S Health Reports (New Rochelle, N.Y.)|September 10, 2025
Improving Communication and Management Following a Positive Home HPV Self-Sampling Result: Comparing Intervention Strategies Between the HOME and STEP TrialsJasmin A Tiro, Meera Muthukrishnan, Sadie Metcalfe, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2010
A circadian-regulated gene, Nocturnin, promotes adipogenesis by stimulating PPAR-gamma nuclear translocationMasanobu Kawai, Carla B Green, Beata Lecka-Czernik, et al.
European Journal of Preventive Cardiology|November 27, 2024
Albiglutide and atrial fibrillation in patients with type 2 diabetes and established cardiovascular disease - insights from the Harmony Outcomes trialKonstantin A Krychtiuk, Guillaume Marquis-Gravel, Shannon Murphy, et al.
Neurosurgery|April 1, 2006
GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysisArash J Gabayan, Sylvan B Green, Abhay Sanan, et al.
American Heart Journal|November 11, 2019
Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOSNeha J Pagidipati, Yinggan Zheng, Jennifer B Green, et al.
Journal of the American Heart Association|January 12, 2021
Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular DiseaseAdam J Nelson, Maddalena Ardissino, Kevin Haynes, et al.
Hypertension (Dallas, Tex. : 1979)|September 14, 2020
Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension: An International Expert Position PaperStefano Omboni, Richard J McManus, Hayden B Bosworth, et al.
Journal of Dairy Science|September 18, 2017
Characterizing effects of feed restriction and glucagon-like peptide 2 administration on biomarkers of inflammation and intestinal morphologyS K Kvidera, E A Horst, M V Sanz Fernandez, et al.
Pageof 135